Trial intelligence / Profile preview

Statins in Spontaneous Intracerebral Hemorrhage

NCT06094244Completed

Sponsor
Pomeranian Medical University in Szczecin
Start
Mar 2017
Primary completion
Dec 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

Open-label trial of atorvastatin and rosuvastatin in intracerebral hemorrhage (ICH) (3 arms), sponsored by Pomeranian Medical University in Szczecin. Primary endpoints: National Institutes of Health Stroke Scale at 90 days, Modified Rankin Scale at 90 days and 2 more. Started Mar 2017; status: completed.

02

Drugs

atorvastatinrosuvastatin
03

Conditions

intracerebral hemorrhage (ICH)

Beyond the preview

Go deeper on NCT06094244.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06094244.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call